Cargando…

Evaluation of nuclear PGAM2 value in hepatocellular carcinoma prognosis

Phosphoglycerate mutase (PGAM) is a critical enzyme in glycolysis. PGAM2 is abundant in several types of tissues and malignant tumours. However, there is limited information regarding their clinicopathological significance in dysplastic nodules and hepatocellular carcinoma (HCC). This study aims to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yi-Ran, Chen, Jin-Dong, Zhu, Yu-Yao, Li, Ju-Tang, Jin, Guang-Zhi, Jin, Ri-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Clinical Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670336/ https://www.ncbi.nlm.nih.gov/pubmed/34321420 http://dx.doi.org/10.1097/CAD.0000000000001150

Ejemplares similares

MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis
por: Huang, Xiao-Ying, et al.
Publicado: (2013)

3D-QSAR, Molecular Docking, and MD Simulations of Anthraquinone Derivatives as PGAM1 Inhibitors
por: Wang, Yuwei, et al.
Publicado: (2021)

High PGAM5 expression induces chemoresistance by enhancing Bcl-xL-mediated anti-apoptotic signaling and predicts poor prognosis in hepatocellular carcinoma patients
por: Cheng, Jingjing, et al.
Publicado: (2018)

Deletion of PGAM5 Downregulates FABP1 and Attenuates Long-Chain Fatty Acid Uptake in Hepatocellular Carcinoma
por: Muthusamy, Ganesan, et al.
Publicado: (2023)

T cell receptor repertoire profiling predicts the prognosis of HBV‐associated hepatocellular carcinoma
por: Lin, Kai‐Rong, et al.
Publicado: (2018)

The clinical significance of lipopolysaccharide binding protein in hepatocellular carcinoma
por: Cai, Quan-Yu, et al.
Publicado: (2020)

PGAM5 deacetylation mediated by SIRT2 facilitates lipid metabolism and liver cancer proliferation: PGAM5 deacetylation facilitates liver cancer proliferation
por: Fu, Gongyu, et al.
Publicado: (2023)

Exosomal PGAM1 promotes prostate cancer angiogenesis and metastasis by interacting with ACTG1
por: Luo, Jun-qi, et al.
Publicado: (2023)

Dysregulation of the NUDT7-PGAM1 axis is responsible for chondrocyte death during osteoarthritis pathogenesis
por: Song, Jinsoo, et al.
Publicado: (2018)

PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression
por: Peng, Jianzhong, et al.
Publicado: (2022)

The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues
por: Pang, Yu‐Yan, et al.
Publicado: (2020)

Clinical Value of Serum LHPP-associated miR-765 in the Prognosis of Laparoscopic or Open Hepatectomy for Hepatocellular Carcinoma
por: Yan, Jingting, et al.
Publicado: (2020)

An independent poor-prognosis subtype of hepatocellular carcinoma based on the tumor microenvironment
por: Wang, Junfeng, et al.
Publicado: (2021)

The prognostic value of Niemann-Pick C1-like protein 1 and Niemann-Pick disease type C2 in hepatocellular carcinoma
por: Chen, Ke-Ji, et al.
Publicado: (2018)

Functional role of PGAM5 multimeric assemblies and their polymerization into filaments
por: Ruiz, Karen, et al.
Publicado: (2019)

The potential value of CDV3 in the prognosis evaluation in Hepatocellular carcinoma
por: Xiao, Heng, et al.
Publicado: (2018)

Proliferating cell nuclear antigen (PCNA) overexpression in hepatocellular carcinoma predicts poor prognosis as determined by bioinformatic analysis
por: Li, Dan-Dan, et al.
Publicado: (2021)

Genomic Aberrations in the HTPAP Promoter Affect Tumor Metastasis and Clinical Prognosis of Hepatocellular Carcinoma
por: Wu, Jin-Cai, et al.
Publicado: (2014)

Mitochondrial phosphatase PGAM5 modulates cellular senescence by regulating mitochondrial dynamics
por: Yu, Bo, et al.
Publicado: (2020)

Epidemiology and Prognosis of Paraneoplastic Syndromes in Hepatocellular Carcinoma
por: Chang, Pik Eu, et al.
Publicado: (2013)

Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery
por: Hou, Gui‐min, et al.
Publicado: (2021)

MicroRNA-24 Modulates Aflatoxin B1-Related Hepatocellular Carcinoma Prognosis and Tumorigenesis
por: Liu, Yi-Xiao, et al.
Publicado: (2014)

Expression of IER3 in hepatocellular carcinoma: clinicopathology, prognosis, and potential regulatory pathways
por: He, Fei-Yan, et al.
Publicado: (2022)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Novel heterozygous mutations in the PGAM2 gene with negative exercise testing
por: Sidhu, M., et al.
Publicado: (2018)

The Ablation of Mitochondrial Protein Phosphatase Pgam5 Confers Resistance Against Metabolic Stress
por: Sekine, Shiori, et al.
Publicado: (2016)

Potential Role and Clinical Value of PPP2CA in Hepatocellular Carcinoma
por: Yang, Cheng-Lei, et al.
Publicado: (2021)

Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation
por: Hitosugi, Taro, et al.
Publicado: (2013)

Prognostic Values of BolA Family Member Expression in Hepatocellular Carcinoma
por: Wang, Dong, et al.
Publicado: (2022)

A poor prognosis in human hepatocellular carcinoma is associated with low expression of DPP4
por: Yu, Hao, et al.
Publicado: (2020)

Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma
por: Sun, Jin‐Yu, et al.
Publicado: (2020)

Clinical Characteristics and Surgical Prognosis of Hepatocellular Carcinoma with Bile Duct Invasion
por: Meng, Ke-Wei, et al.
Publicado: (2014)

High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma
por: Liao, Weijia, et al.
Publicado: (2014)

Type of Necrosis Influences Prognosis in Hepatocellular Carcinoma After the First Transarterial Chemoembolization
por: Wu, Zhi-Juan, et al.
Publicado: (2021)

Prognostic value of systemic inflammation score in patients with hepatocellular carcinoma after hepatectomy
por: Shi, Shiming, et al.
Publicado: (2017)

Correlation Between von Hippel-Lindau Gene Expression and Tumor SUVmax and Survival Prognosis in Hepatocellular Carcinoma
por: Li, Gen, et al.
Publicado: (2020)

Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy
por: Liao, Rui, et al.
Publicado: (2018)

Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
por: Guo, Zheng, et al.
Publicado: (2020)

Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma
por: Li, Quanxiao, et al.
Publicado: (2021)

The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis
por: Tian, Mei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s17rcdngsgo5sog7fbulrgiqvm